Price cuts post the November GST rate rationalisation helped improve volume growth for HUL, what pegged back sales for ITC is adverse social media rumours against Aashirvaad atta, its single-largest FMCG brand.
From MRF to Shree Cement: 23 companies which delivered 30% CAGR in 15 years.
Over-expansion, bad management, and multiple allegations irreparably taint Malvinder and Shivinder Singh
Street may be ignoring TCS headwinds as the stock's peak valuation doesn't seem justified by BFSI weakness, likely higher US tax rates and stronger rupee, reports Ram Prasad Sahu.
In the quarter ended September 30, the Pirojsha Godrej-led firm recorded Rs 492 crore net sales, up 49% year-on-year
What stocks will gain from a normal monsoon?
Falling revenues, increased capex, and first full year of spectrum debt may make things worse
Revenues of Airtel and Idea have been hit by falling realisation and analysts said margins would be affected by higher costs.
I have no hesitation to say that the cultural milieu is different, said chairman R Seshasayee in a rare media interaction.
Ambani said, in the telecom space, the focus will be on debt reduction, and the virtual merger did away with the need for major capex and will help towards this
Can the country afford to have problems of such magnitude in the cities of Gurgaon, Bengaluru, Pune and Hyderabad, which not only are the major growth drivers but are also the biggest revenue contributors in their respective states?
The issue arose after TCS dismissed hundreds of employees in January 2015, leading to the formation of the IT Employees Wing supported by the NDLF.
Almost a third of the company's capex was stuck in this project
Godrej Properties, is on the horizon as it unlocks value in its high-value Bandra-Kurla Complex (BKC) project.
Given its network and fleet, it has garnered the highest share of passenger growth.
The reason is believed to be a 19% increase in interest cost.
Along with a robust set of numbers, the management too sounded confident of its growth prospects
Brokerages have cut the company's FY16 earnings estimates between 16% and 29% with target prices too coming down to the Rs 700-800 band
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
Telcos have indicated that rates will have to be raised, as higher volumes alone will not suffice to meet the higher costs.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances